drugset / Trial / NCT03306667
Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to assess the pharmacokinetics, pharmacodynamics and safety after single oral administration of FYU-981 to subjects with hepatic insufficiency and with normal hepatic function.
Timeline
- Start
- 2017-10-06
- Primary completion
- 2018-06-20
- Completion
- 2018-06-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dotinurad | Small molecule | — | Oral |